CATALOGO DEI PRODOTTI DELLA RICERCA

MILELLA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.474
EU - Europa 14.448
AS - Asia 11.483
SA - Sud America 1.875
Continente sconosciuto - Info sul continente non disponibili 631
AF - Africa 405
OC - Oceania 46
AN - Antartide 1
Totale 47.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.532
RU - Federazione Russa 6.309
SG - Singapore 4.853
CN - Cina 2.619
IT - Italia 2.312
BR - Brasile 1.456
GB - Regno Unito 1.191
HK - Hong Kong 1.119
VN - Vietnam 1.065
DE - Germania 953
FR - Francia 913
IE - Irlanda 734
SE - Svezia 595
FI - Finlandia 500
CA - Canada 440
KR - Corea 382
BD - Bangladesh 335
NL - Olanda 229
IN - India 222
ID - Indonesia 215
AR - Argentina 134
JP - Giappone 126
PL - Polonia 114
MX - Messico 112
ES - Italia 111
UA - Ucraina 105
AT - Austria 94
ZA - Sudafrica 85
TR - Turchia 74
IQ - Iraq 70
EC - Ecuador 65
CO - Colombia 63
CR - Costa Rica 63
GT - Guatemala 54
BJ - Benin 53
TG - Togo 51
VE - Venezuela 51
NG - Nigeria 49
LT - Lituania 44
HN - Honduras 43
TT - Trinidad e Tobago 42
AU - Australia 41
PK - Pakistan 41
CZ - Repubblica Ceca 39
SV - El Salvador 36
JM - Giamaica 35
SA - Arabia Saudita 34
TH - Thailandia 33
UZ - Uzbekistan 31
CL - Cile 30
EG - Egitto 30
MA - Marocco 30
NI - Nicaragua 28
PH - Filippine 28
PR - Porto Rico 27
MY - Malesia 26
BE - Belgio 25
CW - ???statistics.table.value.countryCode.CW??? 25
IR - Iran 25
PY - Paraguay 25
CH - Svizzera 23
JO - Giordania 23
TN - Tunisia 22
AE - Emirati Arabi Uniti 21
UY - Uruguay 21
NP - Nepal 18
PE - Perù 18
GP - Guadalupe 17
KZ - Kazakistan 16
DK - Danimarca 14
DZ - Algeria 14
KE - Kenya 14
RS - Serbia 13
AM - Armenia 12
AZ - Azerbaigian 12
HR - Croazia 12
IL - Israele 12
KG - Kirghizistan 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
LV - Lettonia 11
SN - Senegal 11
RO - Romania 10
EE - Estonia 9
GR - Grecia 9
SC - Seychelles 9
SK - Slovacchia (Repubblica Slovacca) 9
BG - Bulgaria 8
BO - Bolivia 8
PS - Palestinian Territory 8
AL - Albania 7
AO - Angola 7
BB - Barbados 7
BS - Bahamas 7
BY - Bielorussia 7
CY - Cipro 7
EU - Europa 7
LU - Lussemburgo 7
NO - Norvegia 7
TW - Taiwan 7
Totale 46.645
Salva come PNG Salva come JPEG
Città #
Ashburn 2.622
Singapore 2.467
San Jose 2.165
Moscow 2.041
Dallas 1.899
Chandler 1.248
Hong Kong 1.103
Council Bluffs 819
Verona 798
Southend 721
Dublin 697
Beijing 519
The Dalles 447
Ho Chi Minh City 353
Munich 346
New York 346
Los Angeles 341
Woodbridge 339
Jacksonville 298
Princeton 266
Lawrence 265
Santa Clara 245
Houston 229
Hanoi 227
Helsinki 204
Sindelfingen 184
Milan 178
Ann Arbor 176
Buffalo 175
Jakarta 157
São Paulo 152
Redondo Beach 149
Wilmington 141
Redmond 139
Jinan 136
London 131
Tokyo 106
Montreal 102
Chicago 99
Frankfurt am Main 93
Toronto 93
Turku 91
Orem 89
Columbus 88
Nanjing 83
Rome 81
Shenyang 81
Brooklyn 80
Atlanta 79
Seattle 75
Nuremberg 74
Lappeenranta 72
Amsterdam 70
Tianjin 69
Warsaw 67
Hebei 60
Phoenix 59
Meda 58
San Francisco 58
Da Nang 57
Denver 57
Johannesburg 56
Naples 55
Cotonou 53
Lomé 51
McKinney 50
Chennai 49
Guangzhou 49
San José 49
Boardman 48
Ningbo 46
Rio de Janeiro 46
Stockholm 46
Vienna 46
Abuja 45
Changsha 44
Guatemala City 44
North Bergen 44
Seoul 44
Washington 41
Mumbai 40
Zhengzhou 40
Belo Horizonte 39
Boston 38
Haiphong 38
Bologna 37
Hangzhou 36
Mexico City 36
Poplar 36
Cleveland 35
Shanghai 35
Paris 33
San Salvador 33
Kent 32
Nanchang 31
Baghdad 30
Barnet 30
Haikou 30
Las Vegas 30
Charlotte 29
Totale 26.258
Salva come PNG Salva come JPEG
Nome #
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 353
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 333
Genomic characterization of hepatoid tumors: context matters 275
"Running with cancer": A qualitative study to evaluate barriers and motivations in running for female oncological patients 269
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 268
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 234
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 230
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 229
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 227
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 225
Sex differences in oncogenic mutational processes 225
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 223
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 223
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 222
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 220
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 214
Emerging pathways and future targets for the molecular therapy of pancreatic cancer. 211
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 210
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 209
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 209
A Journey through the Multifaceted Landscape of Prostate Cancer: from Bench to Bedside Studies 209
A multimodal approach to cancer-related cachexia: from theory to practice 208
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 207
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 207
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 205
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 197
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 196
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 195
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents. 195
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 195
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 194
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. 188
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 187
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 187
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 187
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 186
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 186
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 183
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 183
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 182
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 182
ERK 1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia 181
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 181
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 180
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 179
Development of Educational Print Materials for Physical Activity in Cancer: Evaluation of Readability and Suitability 179
Pan-cancer analysis of whole genomes 178
Loss of FGFR4 promotes the malignant phenotype of PDAC 177
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen 177
Exercise levels and preferences in cancer patients: a cross-sectional study 177
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 177
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 177
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 176
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 175
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 175
Psychological impact of Covid-19 pandemic on oncological patients: a survey in Northern Italy 174
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 173
A cross-sectional study exploring the perception of exercise oncology in the Italian population 173
JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer 173
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 173
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 173
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 172
Do immune checkpoint inhibitors need new studies methodology? 170
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 170
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 169
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 168
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 168
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 168
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 167
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 167
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 167
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 167
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer 167
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 166
Physical activity guidelines in oncology: a systematic review of the current recommendations 166
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 166
Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A 'Hard Days Night' 165
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 164
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 163
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 163
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy? 163
Muscle derangement and alteration of the nutritional machinery in NSCLC 162
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 162
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 161
Impact of exercise in patients with pancreatic cancer across different treatment phases: a systematic review 161
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 160
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 160
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 159
Multidisciplinary lifestyle intervention to manage pancreatic cancer-related cachexia: a case report 158
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 158
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study 157
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder 156
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials 156
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin 156
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 155
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications 155
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias 155
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 155
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 154
Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer 154
Totale 18.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.013
article - articoli 185.202
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 633
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.178
Totale 374.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.236 0 0 0 108 46 22 37 102 58 37 310 516
2022/20234.036 288 361 381 706 319 1.049 61 221 437 49 103 61
2023/20242.596 91 167 229 358 224 355 205 191 56 125 419 176
2024/20257.921 436 352 331 1.385 349 301 437 438 1.104 624 726 1.438
2025/202623.067 1.493 1.253 2.019 3.565 5.503 1.337 2.003 1.360 1.842 1.358 564 770
2026/20274.963 379 793 1.131 2.660 0 0 0 0 0 0 0 0
Totale 47.363